Fluvoxamine maleate

Analytical Profiles of Drug Substances and Excipients

Volumn 24, Issue C, 1996, Pages 165-208

  Fodal, Nagwa H ^a   Radwan, Mahasen A ^a   Al Deeb, Omar A ^b  

^a University Center for Women Students   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005193901     PISSN: 10756280     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0099-5428(08)60693-0     Document Type: Article

References (47)

1. th ed. Merck and Co. Inc., Rahway, New Jersey, 1989, p. 659.
2. th ed. J. E. F. Reynolds, ed. The Pharmaceutical Press, London, 1994, p. 1450.
3. H. B. A. Welle V. and Claassen, US Patent 4, 085, 225, April 18, 1978.
4. O. M. Al-Gohary, N. H. Foda, and F. El Shafie, Identification of polymorphs of fluvoxamine maleate, Die Pharmazie, 49, 592-594 (1994).
5. O. A. Al Deeb, N. H. Foda, and M. A. Radwan, unpublished results.
6. A. A. Al Haider, M. E. M. Hagga, M. E. Alawady, and E. A. Gad-Kariem, Spectrophotometric determination of fluvoxamine in tablets based on charge-transfer complex with chloranil, Anal. Lett., 26, 887-901 (1993).
7. M. E. M. Hagga, A. A. Al Haider, H. A. Al-Kahmees, M. E. Alawady, and E. A. Gad-Kariem, Evaluation of fluvoxamine maleate in tablets by high performance liquid chromatogrphic and chargetransfer complexation methods, Saudi Pharm. Journal, 1, 70-75 (1993).
8. K. Albert, Polarographic determination of fluvoxamine maleate in tablets, Pz-wiss, 3, 59-61 (1990). (Pubitemid 20257298)
9. M. Tuneel, G. Altiokka, and Z. Atkosar, The polarographic determination of fluvoxamine maleate, Anal Lett., 27, 1135-1145 (1994).
10. C. Schweitzer, H. Span, and E. Mutschler, Fluorimetric determination of fluvoxamine or clovoxamine in human plasma after thin-layer chromatographic or high performance liquidchromatographic separation, J. Chromatgr. Biomed. Appl. 55 (J. Chromatogr., 382) 405-411 (1986). (Pubitemid 17194753)
11. H. E. Hurst, D. R. Jones, C. H. Jarboe, and H. DeBree, Determination of clovoxamine concentration in human plasma by electron capture gas chromatography, Clin. Chem. 27, 1210-1212 (1981). (Pubitemid 11071861)
12. S. Dawling, N. Ward, and E. G. Essex, Rapid measurement of basic drugs in blood applied to clinical forensic toxicology, Ann. Clin. Biochem., 27, 473-477 (1990). (Pubitemid 20340293)
13. J. Keating, L. Dratxu, M. Lader, and R. A. Sherwood, Measurement of plasma serotonin by high-performance liquid chromatography with electrochemical detection as an index of the in vivo activity of fluvoxamine, J. Chromatogr. Biomed. Appl., 126 (J. Chromatogr., 615) 237-242 (1993). (Pubitemid 23171248)
14. S. Haertter, H. Wetzel, and C. Hiemke, Automated determination of fluvoxamine in plasma by column switching high performance liquid chromatography, Clin. Chem., 38, 2082-2086 (1992).
15. V. Van-der-Meersch-Mougeot and B. Diquet, Sensitive one-step extraction procedure for column liquid-chromatogrphic determination of fluvoxamine in human and rat plasma, J. Chromatogr. Biomed. Appl., 105 (J. Chromatogr., 567) 441-449 (1991).
16. J. P. Foglia, L. A. Birder, and J. M. Perel, Determination of fluvoxamine in human plasma by high-performance liquid chromatography with ultra-violet detection, J. Chromatogr. Biomed. Appl., 87, (J. Chromatgr., 495) 295-302 (1989). (Pubitemid 19270574)
17. N. H. Foda, High performacne liquid chromatogrphic determination of fluvoxamine maleate in tablets. J. Liquid. Chromatgr., 18, 1591-1601 (1995).
18. R. H. Pullen and A. A. Fatmi, Determination of fluvoxamine in human plasma by high performance liquid chromatography with fluorescence detection, J. Chromatgr. Biomed. Appl. 112, (J. Chromatogr., 574) 101-107 (1992).
19. P. J. M. Kwakman, H. Koelewijn, J. Kool, U. A. T. Brikman, and G. J. De-Jong, Naphthalene and anthracene-2, 3-dialdehyde as precolumn labelling reagents for primary amines using reversed and normal-phase liquid chromatography with peroxyoxalate chemilurninescence detection, J. Chromatgr., 511, 155-166 (1990). (Pubitemid 20197929)
20. J. Pommery and M. Lhermitte, High-performance liquidchromatographic determination of fluvoxamine in human plasma, Biomed. Chromatogr., 3, 177-179 (1989). (Pubitemid 19211702)
21. N. H. Foda, Compatibility study between fluvoxamine maleate, mebeverine hydrochloride and tablet excipients using differential scanning calorimetry, Egypt J. Pharm. Sci., 33, 73-79 (1992).
22. P. Benfield and A. Ward, Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness, Drugs, 32, 313-334 (1986). (Pubitemid 16028714)
23. L. Conti, L. Dell'Osso, and F. Re F, Fluvoxamine maleate: double-blind clinical trial vs. placebo in hospitalized depressed patients. Curr. Ther. Res., 43, 468-479 (1988).
24. A. J. Martin, V. M. Tebbs, and J. J. Ashford, Affective disorders in general practice. Treatment of 6000 patients with fluvoxamine, Pharmatherapeutica, 5, 40-49 (1987). (Pubitemid 17079528)
25. W. K. Goodman, L. H. Price, and S. A. Rasmussen, Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo, Arch. Gen. Psychiatry, 46, 36-44 (1989). (Pubitemid 19038406)
26. H. DeBree, J. B. Van der Schoot, and L. C. Post, Fluvoxamine maleate: disposition in man, Eur. J. Drug Metab. Pharmacokinet., 8, 175-179 (1983). (Pubitemid 13073278)
27. J. Van Harten, P. Van Bemmel, and M. R. Dobrinska MR, Bioavailability of fluvoxamine given with and without food, Bioparm. Drug Dispos., 12, 571-575 (1991).
28. E. Perucca, Routes of drug administration., Med. Int., 101, 4229-4234 (1992).
29. D. P. Doogan, Fluvoxamine as an antidepressant drug, Neuropharmacology, 19, 1215-1216 (1980). (Pubitemid 11165102)
30. J. Van Harten, Comparative pharmacokinetics of selective serotonin re-uptake inhibitors, Clin. Pharmacokinet., 24, 203-220 (1993). (Pubitemid 23094387)
31. U. A. Siddiqui, S. K. Chakravarti, and D. K. Jesinger, The tolerance and antidepressive activity of fluvoxamine as a single dose compared to a twice daily dose, Curr. Med. Res. Op., 9, 681-690 (1985). (Pubitemid 16203073)
32. M. H. de Vries, M. Raghoebar, and I. S. Mathlener, Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects, Ther. Drug Monitor., 14, 493-498 (1992).
33. H. Overmars, P. M. Scherpenisse, and L. C. Post, Fluvoxamine maleate: metabolism in man. Eur. J. Drug Metabol. Pharmacokinet., 8, 269-280 (1983). (Pubitemid 14230588)
34. V. Claassen, Review of the animal pharmacology and pharmacokinetics of fluvoxamine, Br. J. Clin. Pharmacol., 15 (3 Suppl.), 349S-355S (1983). (Pubitemid 13126940)
35. H. M. Ruijten, H. DeBree, and J. M. Borst, Fluvoxamine: metabolic fate in animals, Drug Metab. Disp., 12, 82-92 (1984). (Pubitemid 14189046)
36. S. Wright, S. Dawling, and J. J. Ashford, Excretion of fluvoxamine in breast milk, Br. J. Clin. Pharmacol., 31, 209 (1991).
37. W. Wagner, B. Plekkenpol, and T. E. Gray, Review of fluvoxamine safety database, Drugs, 43 (Suppl 2), 48-54 (1992).
38. J. P. Ottervanger, P. M. L. A Van den Bemtt, and G. H. P. de Koning, Risk of bleeding during treatment with fluoxetine (Prozac) or fluvoxamine (Fevarin), Ned Tijdschr Geneeskd, 137, 259-261 (1993). (Pubitemid 23044253)
39. M. I. Wilde, G. L. Polsker, and P. Benfielf, Fluvoxamine: An update review of its pharmacology, and therapeutic use in depressive illness, Drugs, 46, 895-924 (1993). (Pubitemid 23329964)
40. M. A. Jenike, S. Hyman, and L. Baer, A controlled trial of fluvoxamine in obsessive-compulsive disorder: implication for a serotonergic theory, Am. J. Psychiatry, 147, 1209-1215 (1990). (Pubitemid 20275377)
41. W. K. Goodman, L. H. Price, and P. L. Delgado, Specificity of of serotonin reuptake inhibitors in the treatment of obsessivecompulsive disorder, Arch. Gen. Psychiatry, 47, 577-585 (1990). (Pubitemid 20189970)
42. th Collegium International Neuro-Psychopharmacologicum; Nice, France; June 28-July 1, 1992.
43. G. K. Mallya, K. White, and C. Waternaux, Short-and long-term treatment of obsessive-compulsive disorder with fluvoxamine, Ann. Clin. Psychiatry, 4, 77-80 (1992).
44. J. Van Harten, R. L. Holland, and K. Wesnes, Influence of multiple-dose administration of fluvoxamine on the pharmacokinetics of benzodiazepine bromazepam and lorazepam: a randomised, cross-over study, Eur. Neuropsychopharmacol., 2, 381 (1992).
45. J. C. Fleishaker and L. K. Hulst, Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of alprazolamin healthy volunteers, Pharm. Res. 9 (Supplement), S-295 (1992).
46. E. Spina, A. Avenoso, and A. M. Pollicino, Carbamazepine coadministration with fluoxetine or fluvoxamine, Ther. Drug Monitor., 15, 247-50 (1993). (Pubitemid 23171911)
47. A. H. Thomson, E. M. McGovern, and P. Bennie, Interaction between fluvoxamine and theophylline, Pharm. J., 249, 137 (1992).